Adverse Drug Reaction Reporting SystemsDrug-Related Side Effects and Adverse ReactionsDrug EruptionsDrug HypersensitivityPharmacovigilanceProduct Surveillance, PostmarketingStevens-Johnson SyndromeExanthemaUrticariaAnaphylaxisPharmacogeneticsSkin DiseasesPolypharmacyDrug MonitoringDrug-Induced Liver InjuryPharmaceutical PreparationsDrug TherapyDrug PrescriptionsDrug LabelingPhotosensitivity DisordersDermatitis, ExfoliativeDrug InteractionsPharmacoepidemiologyAnti-Inflammatory Agents, Non-SteroidalSulfamethoxazoleDiethylcarbamazineChild, HospitalizedOxyphenisatin AcetateProspective StudiesRetrospective StudiesFilaricidesIvermectinAnticonvulsantsErythema MultiformeTreatment OutcomeCatalysisTertiary Care CentersSkin Diseases, EczematousCarbamazepinePharmacology, ClinicalKineticsMedication ErrorsTime FactorsDapsonePharmacyHLA-B15 AntigenFood HypersensitivityAnti-Bacterial AgentsMicrofilariaDouble-Blind MethodDatabases, FactualGastrointestinal DiseasesDrug Therapy, CombinationDesensitization, ImmunologicOnchocerciasisSkin TestsTrimethoprim-Sulfamethoxazole CombinationPharmacistsPharmaceutic AidsHospitals, TeachingGalactorrheaAlkadienesUnited States Food and Drug AdministrationHospitals, PediatricInpatientsHospitalizationAlkenesAnti-Infective AgentsAdministration, OralHospitals, UniversityIncidencePhosphinesDrug Information ServicesOff-Label UseTocolytic AgentsNuclear MedicineEosinophiliaDrug CombinationsDextropropoxypheneClinical Trials as TopicCyclizationPharmacokineticsJapanCosmetic TechniquesAntiveninsTaste DisordersMetabolic Detoxication, DrugDenture, PartialOxidation-ReductionPalladiumRisk FactorsModels, ChemicalOutpatientsDose-Response Relationship, DrugPersonnel, HospitalDrug Administration ScheduleGreat BritainDiclofenacStereoisomerismExtravasation of Diagnostic and Therapeutic Materials